Natural Beauty Bio-Technology (NBBTF) Stock Statistics & Valuation Metrics

Natural Beauty Bio-Technology has a market cap or net worth of $112.29M. The enterprise value is $1.23B.

Market Cap

$112.29M

Enterprise Value

$1.23B

Natural Beauty Bio-Technology has 2,002,101,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

2,002,101,000

Owned by Insiders

―

Owned by Institutions

―

Natural Beauty Bio-Technology’s return on equity (ROE) is 0.02 and return on invested capital (ROIC) is 2.60%.

Return on Equity (ROE)

0.02

Return on Assets (ROA)

0.01

Return on Invested Capital (ROIC)

2.60%

Return on Capital Employed (ROCE)

0.04

Revenue Per Employee

902.56K

Profits Per Employee

17.72K

Employee Count

597

Asset Turnover

0.58

Inventory Turnover

2.58

The current PE Ratio of Natural Beauty Bio-Technology is -15.33. Natural Beauty Bio-Technology’s PEG ratio is 0.01.

PE Ratio

-15.33

PS Ratio

1.68

PB Ratio

2.08

Price to FCF

-6.44

Price to Operating Cash Flow

-15.10

PEG Ratio

0.01

In the last 12 months, Natural Beauty Bio-Technology had revenue of 538.83M and earned 10.58M in profits. Earnings per share was 0.01.

Revenue

538.83M

Gross Profit

293.34M

Operating Income

23.18M

Pretax Income

11.82M

Net Income

10.58M

EBITDA

66.15M

Earnings Per Share (EPS)

0.01

In the last 12 months, operating cash flow was -58.33M and capital expenditures -78.56M, giving a free cash flow of -136.88M billion.

Operating Cash Flow

-58.33M

Free Cash Flow

-136.88M

Free Cash Flow per Share

-0.07

Natural Beauty Bio-Technology pays an annual dividend of $0.00, resulting in a dividend yield of ―

Dividend Per Share

$0.00

Dividend Yield

―

Payout Ratio

N/A

Free Cash Flow Yield

-15.54%

Earnings Yield

-6.52%

Beta

0.25

52-Week Price Change

-20.63%

50-Day Moving Average

0.05

200-Day Moving Average

0.06

Relative Strength Index (RSI)

0.92

Average Volume (3m)

8,130

Natural Beauty Bio-Technology upcoming earnings date is Mar 24, 2027, TBA (Not Confirmed).

Last Earnings Date

Aug 06, 2026

Next Earnings Date

Mar 24, 2027

Ex-Dividend Date

Jun 01, 2022

Natural Beauty Bio-Technology as a current ratio of 1.11, with Debt / Equity ratio of 67.37%

Current Ratio

1.11

Quick Ratio

0.81

Debt to Market Cap

0.30

Net Debt to EBITDA

3.25

Interest Coverage Ratio

2.21

In the past 12 months, Natural Beauty Bio-Technology has paid 1.24M in taxes.

Income Tax

1.24M

Effective Tax Rate

0.10

Natural Beauty Bio-Technology EV to EBITDA ratio is 239.06, with an EV/FCF ratio of -8.70.

EV to Sales

2.27

EV to EBITDA

239.06

EV to Free Cash Flow

-8.70

EV to Operating Cash Flow

-20.41

Natural Beauty Bio-Technology has $116.16M in cash and marketable securities with $424.66M in debt, giving a net cash position of -$308.50M billion.

Cash & Marketable Securities

$116.16M

Total Debt

$424.66M

Net Cash

-$308.50M

Net Cash Per Share

-$0.15

Tangible Book Value Per Share

$0.21

Gross margin is 43.42%, with operating margin of -8.68%, and net profit margin of -10.98%.

Gross Margin

43.42%

Operating Margin

-8.68%

Pretax Margin

-10.44%

Net Profit Margin

-10.98%

EBITDA Margin

0.95%

EBIT Margin

-8.88%

The average price target for Natural Beauty Bio-Technology is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target

―

Price Target Upside

―

Analyst Consensus

―

Analyst Count

―

Revenue Growth Forecast

13.13%

EPS Growth Forecast

7.50%